4PA0
Omecamtiv Mercarbil binding site on the Human Beta-Cardiac Myosin Motor Domain
Experimental procedure
Experimental method | SINGLE WAVELENGTH |
Source type | SYNCHROTRON |
Source details | NSLS BEAMLINE X29A |
Synchrotron site | NSLS |
Beamline | X29A |
Temperature [K] | 100 |
Detector technology | CCD |
Collection date | 2014-02-24 |
Detector | ADSC QUANTUM 315 |
Wavelength(s) | 1.075 |
Spacegroup name | P 1 21 1 |
Unit cell lengths | 100.167, 88.924, 137.786 |
Unit cell angles | 90.00, 93.92, 90.00 |
Refinement procedure
Resolution | 45.961 - 2.250 |
R-factor | 0.2034 |
Rwork | 0.201 |
R-free | 0.24600 |
Structure solution method | MOLECULAR REPLACEMENT |
Starting model (for MR) | 4p7h |
RMSD bond length | 0.011 |
RMSD bond angle | 1.327 |
Refinement software | PHENIX ((phenix.refine: 1.9_1692)) |
Data quality characteristics
Overall | Outer shell | |
Low resolution limit [Å] | 46.042 | 2.290 |
High resolution limit [Å] | 2.250 | 2.250 |
Rmerge | 0.128 | 1.499 |
Number of reflections | 106961 | |
<I/σ(I)> | 7.8 | 0.8 |
Completeness [%] | 93.8 | 84 |
Redundancy | 3.2 | 3.3 |
Crystallization Conditions
crystal ID | method | pH | temperature | details |
1 | VAPOR DIFFUSION, HANGING DROP | 6 | 295 | Tacsimate, pH 6.0, PEG 3350, glycerol, MgCL2, TCEP and ligand, omecamptiv mercarbil |